Find trials
Search tips

Profiling of Blood Immune Biomarkers in Bladder Cancer

Overview

About this study

The purpose of this study is to characterize the immune markers of granulocytes, lymphocytes and monocytes in peripheral blood of newly diagnosed bladder cancer patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Male and female 19 to 85 years with urothelial bladder cancer

Exclusion Criteria: 

  • Age 18 and under
  • Pregnant women
  • Mental abnormalities

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Cheville, M.D.

Closed for enrollment

Contact information:

John Cheville M.D.

(507)284-3867

Cheville.John@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20308380

Mayo Clinic Footer